Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.
Advertisement
Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC [360p]
